GPCR
Structure Therapeutics Inc.NASDAQHealthcare$53.48+6.60%ClosedMarket Cap: $3.08B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.02
P/S
0.00
EV/EBITDA
-13.85
DCF Value
$13.17
FCF Yield
-7.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-14.5%
ROA
-8.9%
ROIC
-11.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $24.0M | $33.0M | $0.60 | — |
| FY 2025 | $0.00 | -Infinity% | $-287.6M | $-141.2M | $-2.40 | — |
| Q3 2025 | $0.00 | NaN% | $-73.8M | $-65.7M | $-1.11 | — |
| Q2 2025 | $0.00 | NaN% | $-70.5M | $-61.7M | $-1.08 | — |
| Q1 2025 | $0.00 | NaN% | $-56.3M | $-46.8M | $-0.81 | — |
| Q4 2024 | $0.00 | NaN% | $-47.1M | $-36.5M | $-0.63 | — |
| FY 2024 | $0.00 | NaN% | $-158.2M | $-122.5M | $-2.34 | — |
| Q3 2024 | $0.00 | NaN% | $-45.8M | $-34.0M | $-0.60 | — |
| Q2 2024 | $0.00 | NaN% | $-33.3M | $-26.0M | $-0.54 | — |
| Q1 2024 | $0.00 | NaN% | $-32.0M | $-26.0M | $-0.57 | — |
| Q4 2023 | $0.00 | NaN% | $-31.0M | $-24.5M | $-0.54 | — |
| FY 2023 | $0.00 | NaN% | $-102.8M | $-89.6M | $-2.43 | — |